SUNPHARMA's weekly return of -2.81% was a disappointing performance, with a Sharpe Ratio of -0.90 indicating that the return was not justified by the level of risk taken. The stock's volatility of 12.47% was relatively lower compared to its peers, but still contributed to a Max Drawdown of -2.99%. SUNPHARMA underperformed DRREDDY and DIVISLAB, but outperformed HINDUNILVR. Overall, the stock was moderately risky this week.

[Volatility: 12.47%]